990 resultados para Tasso, Torquato, 1544-1595.


Relevância:

10.00% 10.00%

Publicador:

Resumo:

迄今为止,铊成矿仅见我国,故研究铊成矿我国应是首开先河。从铊矿床成矿作用研究铊矿床地质地球化学特点,其目的在于强调从生物成矿角度研究微古生物在新陈代谢过程中吸收富集铊成矿和生物残骸积累铊成矿。进而从本质上认识铊在成矿演化过程中地质地球化学和生物化学等多种因素相互作用的特殊成矿机制.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Análises químicas para obtenção. Análises estatísticas dos dados. Modelagem matemática. Determinação dos pontos críticos dos modelos.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Este trabalho explana algumas orientacoes praticas para a criacao de ovinos deslanados no Estado do Amazonas, envolvendo fatores como instalacoes, manejo, alimentacao e sanidade.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

McArdle disease is arguably the paradigm of exercise intolerance in humans. This disorder is caused by inherited deficiency of myophosphorylase, the enzyme isoform that initiates glycogen breakdown in skeletal muscles. Because patients are unable to obtain energy from their muscle glycogen stores, this disease provides an interesting model of study for exercise physiologists, allowing insight to be gained into the understanding of glycogen-dependent muscle functions. Of special interest in the field of muscle physiology and sports medicine are also some specific (if not unique) characteristics of this disorder, such as the so-called 'second wind' phenomenon, the frequent exercise-induced rhabdomyolysis and myoglobinuria episodes suffered by patients (with muscle damage also occurring under basal conditions), or the early appearance of fatigue and contractures, among others. In this article we review the main pathophysiological features of this disorder leading to exercise intolerance as well as the currently available therapeutic possibilities.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Signaturas: [¶]4, A-Q8, R4.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

This technical report presents a combined solution for two problems, one: tracking objects in 3D space and estimating their trajectories and second: computing the similarity between previously estimated trajectories and clustering them using the similarities that we just computed. For the first part, trajectories are estimated using an EKF formulation that will provide the 3D trajectory up to a constant. To improve accuracy, when occlusions appear, multiple hypotheses are followed. For the second problem we compute the distances between trajectories using a similarity based on LCSS formulation. Similarities are computed between projections of trajectories on coordinate axes. Finally we group trajectories together based on previously computed distances, using a clustering algorithm. To check the validity of our approach, several experiments using real data were performed.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

We define a unification problem ^UP with the property that, given a pure lambda-term M, we can derive an instance Gamma(M) of ^UP from M such that Gamma(M) has a solution if and only if M is beta-strongly normalizable. There is a type discipline for pure lambda-terms that characterizes beta-strong normalization; this is the system of intersection types (without a "top" type that can be assigned to every lambda-term). In this report, we use a lean version LAMBDA of the usual system of intersection types. Hence, ^UP is also an appropriate unification problem to characterize typability of lambda-terms in LAMBDA. It also follows that ^UP is an undecidable problem, which can in turn be related to semi-unification and second-order unification (both known to be undecidable).

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Complex diseases will have multiple functional sites, and it will be invaluable to understand the cross-locus interaction in terms of linkage disequilibrium (LD) between those sites (epistasis) in addition to the haplotype-LD effects. We investigated the statistical properties of a class of matrix-based statistics to assess this epistasis. These statistical methods include two LD contrast tests (Zaykin et al., 2006) and partial least squares regression (Wang et al., 2008). To estimate Type 1 error rates and power, we simulated multiple two-variant disease models using the SIMLA software package. SIMLA allows for the joint action of up to two disease genes in the simulated data with all possible multiplicative interaction effects between them. Our goal was to detect an interaction between multiple disease-causing variants by means of their linkage disequilibrium (LD) patterns with other markers. We measured the effects of marginal disease effect size, haplotype LD, disease prevalence and minor allele frequency have on cross-locus interaction (epistasis). In the setting of strong allele effects and strong interaction, the correlation between the two disease genes was weak (r=0.2). In a complex system with multiple correlations (both marginal and interaction), it was difficult to determine the source of a significant result. Despite these complications, the partial least squares and modified LD contrast methods maintained adequate power to detect the epistatic effects; however, for many of the analyses we often could not separate interaction from a strong marginal effect. While we did not exhaust the entire parameter space of possible models, we do provide guidance on the effects that population parameters have on cross-locus interaction.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Withdrawals of high-profile pharmaceuticals have focused attention on post-approval safety surveillance. There have been no systematic assessments of spending on postapproval safety. We surveyed drug manufacturers regarding safety efforts. Mean spending on postapproval safety per company in 2003 was 56 million dollars (0.3 percent of sales). Assuming a constant safety-to-sales ratio, we estimated that total spending on postapproval safety by the top twenty drug manufacturers was 800 million dollars in 2003. We also examined, using regression analysis, the relationship between the number of safety personnel and the number of initial adverse-event reports. This study offers information for the debate on proposed changes to safety surveillance.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

We examined trends in the introduction of new chemical entities (NCEs) worldwide from 1982 through 2003. Although annual introductions of NCEs decreased over time, introductions of high-quality NCEs (that is, global and first-in-class NCEs) increased moderately. Both biotech and orphan products enjoyed tremendous growth, especially for cancer treatment. Country-level analyses for 1993-2003 indicate that U.S. firms overtook their European counterparts in innovative performance or the introduction of first-in-class, biotech, and orphan products. The United States also became the leading market for first launch.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

The evolution of pharmaceutical competition since Congress passed the Hatch-Waxman Act in 1984 raises questions about whether the act's intended balance of incentives for cost savings and continued innovation has been achieved. Generic drug usage and challenges to brand-name drugs' patents have increased markedly, resulting in greatly increased cost savings but also potentially reduced incentives for innovators. Congress should review whether Hatch-Waxman is achieving its intended purpose of balancing incentives for generics and innovation. It also should consider whether the law should be amended so that some of its provisions are brought more in line with recently enacted legislation governing approval of so-called biosimilars, or the corollary for biologics of generic competition for small-molecule drugs.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Infectious and parasitic diseases create enormous health burdens, but because most of the people suffering from these diseases are poor, little is invested in developing treatments. We propose that developers of treatments for neglected diseases receive a "priority review voucher." The voucher could save an average of one year of U.S. Food and Drug Administration (FDA) review and be sold by the developer to the manufacturer of a blockbuster drug. In a well-functioning market, the voucher would speed access to highly valued treatments. Thus, the voucher could benefit consumers in both developing and developed countries at relatively low cost to the taxpayer.